The global number of people with Alzheimer’s disease (AD) doubles every 5 years. It has been established that unless an effective treatment for AD is found, the incidence of AD will triple by 2060. However, pharmacological therapies for AD have failed to show effectiveness and safety. Therefore, the search for alternative methods for treating AD is an urgent problem in medicine. The lymphatic drainage and removal system of the brain (LDRSB) plays an important role in resistance to the progression of AD. The development of methods for augmentation of the LDRSB functions may contribute to progress in AD therapy. Photobiomodulation (PBM) is considered to be a non-pharmacological and safe approach for AD therapy. Here, we highlight the most recent and relevant studies of PBM for AD. We focus on emerging evidence that indicates the potential benefits of PBM during sleep for modulation of natural activation of the LDRSB at nighttime, providing effective removal of metabolites, including amyloid-β, from the brain, leading to reduced progression of AD. Our review creates a new niche in the therapy of brain diseases during sleep and sheds light on the development of smart sleep technologies for neurodegenerative diseases.
1 January 2022 in Computer Methods in Applied Mechanics and Engineering
The aim of this guideline is to assist physicians in the management of patients with cardiovascular pathology and obstructive sleep-disordered breathing. The article consists data on diagnostic tactics for patients with possible sleep-breathing disorders, describes the basic principles of obstructive sleep apnea treatment, and substantiates the clinical significance of obstructive sleep apnea therapy initiating in the management of patients with cardiovascular diseases.
9 September 2019 in Modelling and Simulation in Materials Science and Engineering
There is a range of practical problems where advanced engineering heterogeneous materials undergo chemical transformations. The primary example of such system is energy storage materials, in particular anodes of Li-ion batteries containing active Si particles. The exploitation of such anodes involves extreme volumetric expansion of the active particles during the chemical reaction. The expansion is causing mechanical stress, which, in turn, influences the kinetics of chemical reactions even up to their arrest. A particular reaction between Si and Li is localised, as well as a number of other reactions, such as oxidation or precipitate formation. The model presented in this paper accounts for the kinetics of the reactions in a collection of particles inside a matrix material. The microstructure is modelled using the multiscale mean-field (MF) framework based on the incremental Mori–Tanaka (IMT) method. This is the first application of a multiscale MF technique to modelling reaction front kinetics in particles and linking the intra-particle kinetics with the response of the matrix. A number of physical effects arising from the influence of the deformation mechanisms of the matrix on the kinetics of the intra-particle reactions is investigated. Furthermore, the applicability of the proposed model and the IMT homogenisation scheme is studied by comparison to the full-field simulations in the cases of small and finite strains.
Melatonin is a special hormone that act as an internal synchronizer of circadian rhythms, the organism physiology and behavior to the environmental day and night and seasons of the year. The present urban society and the industrial production processes as organized should be considered, as both depend on the presence of indoor lights during the night and include the profuse use of electronic devices whose screens are rich in blue wavelength light. Light during the night delays the beginning of the secretory episode of melatonin and blunts its peak, causing chronic hypomelatoninemia. Hypomelatonemia, that causes deprivation of sleep and eating behavior disorders, along with low physical activity, can be the reason of the obesity, «non-infectious epidemic of the 21st century». According to this, the use of melatonin drugs for obesity treatment can be effective. Further prospective, controlled, randomized trials in this area are required to confirm this hypothesis.
23 June 2021 in Neuroscience and Behavioral Physiology